N. Hoca Et Al. , "Clinical features and treatment outcomes of pulmonary actinomycosis," European Review for Medical and Pharmacological Sciences , vol.26, no.21, pp.8064-8072, 2022
Hoca, N. Et Al. 2022. Clinical features and treatment outcomes of pulmonary actinomycosis. European Review for Medical and Pharmacological Sciences , vol.26, no.21 , 8064-8072.
Hoca, N., Berktaş, M., Söyler, Y., Celep, C., & Tanrikulu, F., (2022). Clinical features and treatment outcomes of pulmonary actinomycosis. European Review for Medical and Pharmacological Sciences , vol.26, no.21, 8064-8072.
Hoca, NEVİN Et Al. "Clinical features and treatment outcomes of pulmonary actinomycosis," European Review for Medical and Pharmacological Sciences , vol.26, no.21, 8064-8072, 2022
Hoca, NEVİN T. Et Al. "Clinical features and treatment outcomes of pulmonary actinomycosis." European Review for Medical and Pharmacological Sciences , vol.26, no.21, pp.8064-8072, 2022
Hoca, N. Et Al. (2022) . "Clinical features and treatment outcomes of pulmonary actinomycosis." European Review for Medical and Pharmacological Sciences , vol.26, no.21, pp.8064-8072.
@article{article, author={NEVİN TACİ HOCA Et Al. }, title={Clinical features and treatment outcomes of pulmonary actinomycosis}, journal={European Review for Medical and Pharmacological Sciences}, year=2022, pages={8064-8072} }